Abstract
Abstract The most viable therapy for curing type 1 diabetes mellitus is pancreatic islet transplantation. However, they are unavoidable in terms of immunogenicity, which is differently affected by transplantation site. Therefore, it is necessary to determine alternate sites to permit successful islet transplantation outcomes. This paper reviews evidence that the anterior chamber of the eye (ACE) could be a good site for islet transplantation when compared to other alternate sites. In addition, this site may be a promising technical platform for noninvasive in vivo imaging of transplanted pancreatic islets.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
